If you would like to ask our webinar guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPLZL.L Regulatory News (PLZL)

  • There is currently no data for PLZL

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Consent Solicitation Results

9 Sep 2022 09:00

RNS Number : 9198Y
Polyus Finance PLC
09 September 2022
 

9 September 2022

Polyus Finance Plc announces the results of the Consent Solicitation for 2028 Notes

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO, OR TO ANY PERSON LOCATED OR RESIDENT IN, ANY JURISDICTION WHERE IT IS UNLAWFUL TO RELEASE, PUBLISH OR DISTRIBUTE THIS ANNOUNCEMENT OR THE MEMORANDUM.

Polyus Finance Plc (the "Issuer") today formally announces that it has concluded its consent solicitation (the "Consent Solicitation") in relation to the outstanding U.S.$700,000,000 3.25% Guaranteed Notes due 2028 (the "2028 Notes") issued by the Issuer on the terms and subject to the conditions set forth in the Consent Solicitation Memorandum dated 20 July 2022 (the "Memorandum"). Capitalised terms used in this announcement but not defined herein have the meanings given to them in the Memorandum.

The Issuer thanks all Noteholders who have responded promptly and participated in the Consent Solicitation and notifies that the Requisite Consents from the Noteholders of the 2028 Notes were obtained before the Consent Deadline (08 September 2022 5:00 p.m. (London time)).

Consents were distributed in the following way from outstanding amount of the notes:

· 2028 Notes - 77.07%

Consequently, the amendment and waiver of certain terms of the Trust Deed, Paying Agency Agreement and Terms and Conditions of the 2028 Notes have been approved by the Written Resolutions.

As of the Effective Time, I2 Capital Trust Corporation Ltd will act as the new trustee in respect of the 2028 Notes.

The following table sets forth details of the 2028 Notes:

Description of the 2028 Notes

ISIN Code/

Common Code

(Regulation S Notes)

ISIN Code/

Common Code/

CUSIP Code

(Rule 144A Notes)

Outstanding Principal Amount

U.S.$700,000,000 3.25% Guaranteed Notes due 2028

XS2396900685

239690068

US73181LAB71

239725104

73181LAB7

U.S.$700,000,000

 

Forward-looking statements

This announcement may contain "forward-looking statements" concerning Polyus group. Generally, the words "will", "may", "should", "could", "would", "can", "continue", "opportunity", "believes", "expects", "intends", "anticipates", "estimates" or similar expressions identify forward-looking statements. The forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those expressed in the forward-looking statements. Forward-looking statements include statements relating to future capital expenditures and business and management strategies and the expansion and growth of Polyus group's operations. Many of these risks and uncertainties relate to factors that are beyond Polyus group's ability to control or estimate precisely and therefore undue reliance should not be placed on such statements which speak only as at the date of this announcement. The Issuer and/or any Polyus group company assumes no obligation in respect of, and does not intend to update, these forward-looking statements, except as required pursuant to applicable law.

DISCLAIMER

This announcement must be read in conjunction with the Memorandum. 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCGRGDCCSGDGDC
Date   Source Headline
23rd Sep 20202:53 pmRNSPolyus to consolidate 100% of SL Gold
22nd Sep 20202:35 pmRNSResults of exercise of pre-emptive right
22nd Sep 202012:33 pmRNSConsolidation of Lenzoloto assets
7th Sep 20207:53 amRNS1H 2020 Dividend Recommendation
7th Sep 20207:29 amRNSNotice of EGM - replacement
7th Sep 20207:00 amRNSFinancial results for the second quarter of 2020
1st Sep 20209:06 amRNSNotice of financial results 2Q2020
20th Aug 202011:20 amRNSNotice of EGM - Replacement
20th Aug 20209:19 amRNSNotice of EGM
20th Aug 20209:12 amRNSAppointment of Senior Independent Director
19th Aug 20201:44 pmRNSResult of AGM
17th Aug 20207:29 amRNSConsolidation of Lenzoloto assets
7th Aug 202010:54 amRNSThe commencement date of placement of the shares
7th Aug 20207:00 amRNSPre-emption right notice
6th Aug 20205:52 pmRNSDetermination of the issuance price
30th Jul 20205:48 pmRNSDirector/PDMR Shareholding
16th Jul 20207:00 amRNSTrading update for the second quarter of 2020
15th Jul 20203:52 pmRNS2H 2019 Dividend Recommendation and 2019 AGM
23rd Jun 20203:08 pmRNSEGM results
1st Jun 20207:00 amRNSFinancial results for the first quarter of 2020
28th May 20209:10 amRNSDirector/PDMR Shareholding
22nd May 20202:20 pmRNSNotice of financial results for 1Q2020
18th May 20204:05 pmRNSThe proposed placement of new ordinary shares
18th May 20203:44 pmRNSNotice of EGM
14th May 20203:07 pmRNSCompletion of the early redemption
14th May 20202:57 pmRNSCompletion of the early redemption
11th May 202012:01 pmRNSDirector/PDMR Shareholding
30th Apr 20206:30 pmRNSPolyus publishes its 2019 Annual Review
30th Apr 20201:15 pmRNSDirector/PDMR Shareholding
29th Apr 20204:14 pmRNSOre Reserves and Mineral Resources Update
29th Apr 20203:46 pmRNSDirector/PDMR Shareholding
23rd Apr 20207:00 amRNSTrading update for the first quarter of 2020
17th Apr 20205:29 pmRNSDirector/PDMR Shareholding
17th Apr 20205:02 pmRNSOptional redemption of 2021 convertible bonds
17th Apr 20204:45 pmRNSNotice to Bondholders: Optional Redemption Notice
30th Mar 20205:36 pmRNSCompany update on COVID-19 prevention procedures
26th Mar 20205:17 pmRNSDirector/PDMR Shareholding
26th Mar 20203:07 pmRNSEstablishment of a COVID-19 Fund
19th Feb 20204:38 pmRNSPolyus' MSCI ESG rating upgraded to A
11th Feb 20207:00 amRNSFinancial results for 4Q and FY2019
4th Feb 20207:00 amRNSNotice of financial results for 4Q and FY2019
28th Jan 20207:00 amRNSTrading update for 4Q and FY2019
24th Jan 20207:00 amRNSS&P Global Ratings revises Outlook on PJSC Polyus
31st Dec 20197:46 amRNSDirector/PDMR Shareholding
27th Dec 201911:23 amRNSResults of the share issuance
27th Dec 201911:12 amRNSResults of the closed subscription for shares
24th Dec 20191:01 pmRNSResults of exercise of pre-emption right
24th Dec 201911:08 amRNSDirector/PDMR Shareholding
6th Nov 20195:51 pmRNSNew shares issuance update
6th Nov 20194:24 pmRNSNotice of pre-emption right

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.